SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ristimaki A)
 

Sökning: WFRF:(Ristimaki A) > Finnish National Es...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003242naa a2200397 4500
001oai:prod.swepub.kib.ki.se:141251926
003SwePub
008240913s2019 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1412519262 URI
024a https://doi.org/10.1136/bmjopen-2018-0240942 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Kauppila, JHu Karolinska Institutet4 aut
2451 0a Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland
264 c 2019-01-15
264 1b BMJ,c 2019
520 a Surgery for oesophageal and gastric cancers is associated with high morbidity, mortality and poor quality of life postoperatively. The Finnish National Esophago-Gastric Cancer Cohort has been established with the aim of identifying factors that could contribute to improved outcomes in oesophago-gastric cancer.Methods and analysisAll patients with oesophageal and gastric cancer diagnosed in Finland between 1987 and 2015 will be identified from the Finnish national registries. The Finnish Cancer Registry and Finnish Patient Registry will be used to identify patients that fulfil the inclusion criteria for the study: (1) diagnosis of oesophageal, gastro-oesophageal junction, or gastric cancer, (2) any surgical treatment for the diagnosed cancer and (3) age of 18 or over at the time of diagnosis. Clinical variables and complication information will be retrieved in extensive data collection from the medical records of the relevant Finnish hospitals and complete follow-up for vital status from Statistics Finland. Primary endpoint is overall all-cause mortality and secondary endpoints include complications, reoperations, medication use and sick leaves. Sub-studies will be implemented within the cohort to investigate specific populations undergoing oesophageal and gastric cancer surgery. The initial estimated sample size is 1800 patients with surgically treated oesophageal cancer and 7500 patients with surgically treated gastric cancer.Ethics and disseminationThe study has been approved by the Ethical Committee in Northern Ostrobothnia, Finland and The National Institute for Health and Welfare, Finland. Study findings will be disseminated via presentations at conferences and publications in peer-reviewed journals.
700a Ohtonen, P4 aut
700a Karttunen, TJ4 aut
700a Kokkola, A4 aut
700a Laine, S4 aut
700a Rantanen, T4 aut
700a Ristimaki, A4 aut
700a Rasanen, JV4 aut
700a Saarnio, J4 aut
700a Sihvo, E4 aut
700a Toikkanen, V4 aut
700a Tyrvainen, T4 aut
710a Karolinska Institutet4 org
773t BMJ opend : BMJg 9:1, s. e024094-q 9:1<e024094-x 2044-6055
856u https://bmjopen.bmj.com/content/bmjopen/9/1/e024094.full.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141251926
8564 8u https://doi.org/10.1136/bmjopen-2018-024094

Hitta via bibliotek

  • BMJ open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy